Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749683 · ClinicalTrials.gov registry record
Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 100
- Enrollment target
NCT01749683 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 100 participants.
The verdict
NCT01749683 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to study and compare short/long term change of myocardial perfusion abnormality and cardiac outcome in diabetic patients after nonfatal MI (heart attack), who are treated with different glucose control agents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749683
The ClinicalTrials.gov registry entry for NCT01749683 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01749683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01749683 about?
NCT01749683 is a clinical study titled "Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction". The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to study and compare short/long term change of myocardial perfusion abnormality and cardiac outcome in diabetic patients after nonfatal MI (heart attack), who are treated with different glucose control agents.
What is the current status of trial NCT01749683?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2011-08. Estimated completion is 2017-08.
Who is sponsoring clinical trial NCT01749683?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.